Menu
Menu
GLP-1 weight loss from a real medical practice in Palm Harbor, not a subscription service. Every prescription is paired with an in-person physician exam, baseline labs, and a monthly visit with body composition scanning so we know you are losing fat, not muscle.
Semaglutide mimics glucagon-like peptide-1 (GLP-1), a hormone your gut naturally releases after eating. It slows gastric emptying, reduces hunger between meals, and helps regulate blood sugar. The net effect is fewer cravings, smaller portions, and steady weight loss without the white-knuckle willpower that defeats most diets.
The compounded formulation we prescribe is prepared by a licensed US compounding pharmacy and dosed to match the titration schedule used in the landmark STEP clinical trial program. Every vial ships directly to your door once your provider has cleared you, and we bundle the needed syringes and alcohol swabs so there’s nothing for you to source.
You can read our full medical weight loss program overview if you want the bigger picture, or jump to compounded tirzepatide if you’ve already been told you’d be a better fit for the dual-agonist option.
Three steps, one provider, no shortcuts.
A visit at our Palm Harbor clinic to review your history, weight-loss goals, and current medications. We decide together whether semaglutide is the right fit for you.
Baseline labs (A1c, kidney, thyroid, lipid panel) plus an InBody body composition scan that separates fat mass from skeletal muscle. Your physician builds a dosing plan off those numbers and sets realistic milestones for the first 12 weeks.
An in-person visit every four weeks: exam, weight, repeat InBody scan, and a dose decision based on what the scan and your labs show. Same physician every visit, direct line by text or phone in between.
Online GLP-1 services sell access to a prescription. They do a questionnaire, ship a vial, and disappear until you want a refill. The problem is that semaglutide is a medication, not a supplement. Thyroid risk, pancreatitis risk, gallbladder changes, and nutritional deficiencies are all real considerations that require labs and follow-up to catch early.
At Olympia Aesthetics & Wellness you see the same provider before you start, during the titration phase, and all the way through maintenance. You have someone who knows your name if you call with a question, and a medical record that reflects what’s actually happening in your body instead of what you checked in a form.
If you’re considering switching from a telehealth provider, bring your last set of labs and a list of your current doses. We’ll build on what you’ve already done rather than restart.
Semaglutide for weight management was studied in the STEP trial program (Semaglutide Treatment Effect in People with Obesity). The flagship trial, STEP 1 (Wilding et al., New England Journal of Medicine, 2021), followed 1,961 adults with obesity for 68 weeks. The average weight loss on 2.4 mg weekly was 14.9% of starting body weight, compared with 2.4% for placebo. About one in three participants lost more than 20% of their body weight.
Cardiovascular benefit was confirmed in SELECT (Lincoff et al., NEJM, 2023), which showed a 20% relative reduction in major adverse cardiovascular events among patients with overweight or obesity and preexisting cardiovascular disease. These findings were the basis for Wegovy’s FDA label update for cardiovascular risk reduction.
Most patients notice appetite change within the first two weeks. Visible weight loss usually begins around week four to six and builds as the dose titrates upward. The slow-and-steady pattern is part of the safety profile, which is why we resist compressing the titration even when patients want faster results.
Week 1–2. Starting dose of 0.25 mg weekly. Most patients feel reduced appetite within days. Some mild nausea or fullness is common; it almost always improves by week three. We send tips on meal timing, hydration, and protein targets.
Week 3–4. Dose increases to 0.5 mg. Appetite suppression is noticeably stronger. Many patients start seeing 2–4 lbs of weight loss per week. We schedule a 15-minute virtual check-in to troubleshoot any side effects.
Week 5–8. Dose advances to 1.0 mg if tolerated. This is where most patients hit their groove. You’re eating smaller portions naturally, not thinking about food between meals, and noticing clothing fit differently.
Week 9–12. Most patients settle into 1.0–1.7 mg as a working dose. We repeat a brief lab panel to confirm kidney and thyroid function remain stable. From here, care is monthly and focused on long-term behavior change plus dose management.
Anyone can put semaglutide in a box and ship it. This is what the monthly visit is actually for.
Vitals, blood pressure, and an abdominal and thyroid exam with Oliver Morris, DO. Nausea you should expect and gallbladder pain you should not look almost identical through a chat window. In the room, they do not.
The bathroom scale cannot tell fat from muscle. InBody can. Sixty seconds on the device splits your weight into fat mass, skeletal muscle mass, and body water, so we know the pounds coming off are the pounds you wanted off.
A1c, kidney, liver, thyroid, and lipids before your first dose, repeated on schedule. Undiagnosed thyroid disease, fatty liver, and early kidney strain surface here first. None of them surface on a questionnaire.
Subscription programs step your dose up on a shipping schedule. We hold, slow, split, or advance based on your labs, your scan, and how the last four weeks actually went.
Protein targets set against your goal weight, resistance training guidance, and monthly proof from your scan. Fast loss without this quietly costs you lean mass you will want back.
Most people regain when semaglutide stops without one. We write the exit plan at your first visit rather than improvising it at month nine.
The same doctor writes every prescription and sees you at every visit. No rotating prescriber pool, no per-message fees, no support queue.
Rapid loss changes skin and facial volume. Low testosterone and obesity travel together in men over 35. Nutrition, peptides, TRT, and aesthetics are all under the same roof here.
Some people should not be on a GLP-1, and some should be worked up for something else first. An online form will sell to every one of them. We turn people away at the consult, and we tell you why.
We are not going to tell you semaglutide is hard to get. It is easy to get. What is hard to get is someone paying attention while you are on it.
Both routes can put semaglutide in your hand. Only one of them is watching what it does to you.
Brand-name semaglutide is no longer the thousand-dollar-a-month product it was two years ago. Novo Nordisk now sells Wegovy directly to self-pay patients at a fraction of the old pharmacy counter price, and the whole market has moved with it. We are not going to build a pitch on savings that no longer exist.
So here is the straight version. If the lowest possible price on the molecule is your only variable, buying a brand pen direct is a legitimate option, and we will tell you so at your consult rather than talk you out of it. What we charge for is not a discount on a drug. It is the medicine around the drug: the physical exam, the baseline and follow-up labs, the monthly InBody scan, dose decisions made on your data instead of a shipping calendar, and a physician who answers when something goes wrong at 8pm on a Sunday.
We are also not locked into compounded. If a brand product is the better fit for your dose, your insurance, or your tolerance, we will write it and manage you on it. The care is the same either way.
Program pricing depends on your dose and the length of the program, and covers the medication, supplies, your monthly in-person visit, and your body composition scans. Labs are billed separately at wholesale. We do not bill insurance directly for compounded medications, but we provide superbills for HSA or FSA reimbursement and offer CareCredit for patients financing a full 12-month program up front. You get exact numbers at the consultation, including what the brand route would cost you, before you commit to anything.
In the STEP 1 trial, patients lost an average of 14.9% of their starting body weight over 68 weeks at the full 2.4 mg dose. Real-world results vary with nutrition, activity, and how long you stay on therapy. Most of our patients land in the 10 to 15% range over the first year.
Most people notice reduced appetite within the first two weeks. Visible weight loss usually starts by week four to six and continues steadily as your dose titrates upward. The biggest changes happen between months three and nine.
Nausea, reflux, constipation, and early fullness are the most common, and they are almost always dose-related. They tend to improve after the first few weeks. We titrate slowly to minimize them, and we have a detailed toolkit for managing each one.
Rarely, GLP-1 therapy can trigger pancreatitis, gallbladder disease, or worsen preexisting gastroparesis. We screen for these risks at your initial visit and teach you the symptoms to report. Your labs catch most issues before they become problems.
The active ingredient is the same. Ozempic (type 2 diabetes) and Wegovy (weight loss) are Novo Nordisk brand products; ours is prepared by a licensed US compounding pharmacy. Brand self-pay pricing has come down a great deal, so the two are much closer on cost than they used to be. We prescribe both and will recommend whichever fits your dose, tolerance, and budget at the consult.
The monthly program covers the medication, supplies, your in-person follow-up visit with the physician, and your InBody body composition scan. Pricing depends on your dose and program length. Labs are billed separately at wholesale. We give you exact numbers at the consultation, including what the brand-name route would cost you, so you can compare the two honestly.
Many patients taper to a maintenance dose once they hit their target. Stopping abruptly often leads to appetite returning and weight regain within three to six months, so we wean down gradually under supervision.
In most cases yes, but we review your full medication list at the consult. There are specific interactions (oral contraceptives, certain diabetes meds, thyroid replacement) that we account for. If you’re on insulin or sulfonylureas, dosing needs a careful adjustment.
A plateau around month six is not unusual. We troubleshoot nutrition, activity, and dose first. If you’ve plateaued despite optimization, we may switch you to compounded tirzepatide, which works on a second receptor pathway.
Oliver Morris, DO is the prescribing physician. You’ll meet him at your first visit and see him for follow-up throughout your program. Read his full bio on the Oliver Morris, DO page.
Fair question, and the price drop is real. What a pharmacy or a website sells you is the drug. What we sell is the drug plus the medicine around it: a physical exam, labs that get repeated, a monthly body composition scan so we can prove you are losing fat rather than muscle, dose decisions made on your data, and a physician who picks up the phone when something goes wrong. If you would rather have the vial and manage the rest yourself, that is a reasonable choice and we will say so. We just will not pretend the two are the same thing.
Yes. We are not locked into compounded medication. If the brand product is the better fit for your dose, your coverage, or your tolerance, we will write it and manage you on it. The exam, labs, scans, and follow-up are identical either way.
InBody is a body composition analyzer. You stand on it for about a minute and it separates your weight into fat mass, skeletal muscle mass, and body water. It matters on GLP-1 therapy because a meaningful share of rapid weight loss can come from muscle if nobody is watching. The monthly scan is what tells us whether to advance your dose, hold it, or fix your protein and training first. A scale at home cannot tell you any of that.
Yes, and it is the part of the program that does the most work. The monthly visit is where the exam happens, where the scan gets repeated, and where your dose actually gets decided. Patients who skip in-person follow-up are the ones who plateau on the wrong dose, lose muscle without knowing it, or sit on a side effect that should have been addressed weeks earlier. Visits run about 20 minutes and we keep to schedule.
References
If you’re a candidate, we’ll build your plan at the first visit and start labs the same day. Complimentary phone consultation available.
Contact information is for the sole use of
Olympia Aesthetics & Wellness and will not be redistributed.
Olympia Aesthetics & Wellness
33295 US Hwy 19 N #109
Palm Harbor, FL 34684
(727) 274-1972
Get directions
10 am – 6 pm Monday
10 am – 6 pm Tuesday
10 am – 6 pm Wednesday
10 am – 6 pm Thursday
10 am – 6 pm Friday
10 am – 2 pm Saturday
10 am – 2 pm Sunday
Accessibility: Olympia Aesthetics & Wellness is committed to ensuring our website is accessible to all users. If you experience any difficulty, please contact us at (727) 274 – 1972 or olympia@olympiaaesthetics.com. Click for more details